Chrome Extension
WeChat Mini Program
Use on ChatGLM

Nivolumab and Ipilimumab for Metastatic Prostate Cancer with an Immunogenic Signature: the NEPTUNES Multi-Centre Two-Cohort, Biomarker-Selected Phase 2 Trial.

JOURNAL OF CLINICAL ONCOLOGY(2024)

Cited 0|Views5
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined